MedTrace Logo

Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

NCT02544776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-03-25

No results posted yet for this study

Summary

On the basis of the current study, amlodipine seems to be a promising drug on improving uterine, ovarian blood flow, size of pre-ovulatory follicle, midluteal progesterone level and pregnancy outcome in patients with pco.

Conditions

  • Female Infertility Associated With Anovulation

Interventions

DRUG

Clomifene citrate ( clomid 50 mg )

DRUG

Amlodipine

Sponsors & Collaborators

  • Ahmed Fathy Ali Mohamed Ghanem

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-08-31
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02544776 on ClinicalTrials.gov